CAMBRIDGE, Mass.--(BUSINESS WIRE)--Civetta Therapeutics, LLC, a biotechnology company focused on developing a pipeline of therapies that target beta-propeller proteins, today announced that ...
Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Civetta Therapeutics, LLC, a biotechnology company focused on developing a pipeline of therapies that target beta-propeller proteins, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results